Cipla Gets Regulatory Nod To Sell COVID-19 Drug - The Purbottar<\/title>\n<meta name=\"description\" content=\"Cipla has received regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drug maker said on Friday, as coronavirus infections in\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cipla Gets Regulatory Nod To Sell COVID-19 Drug - The Purbottar\" \/>\n<meta property=\"og:description\" content=\"Cipla has received regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drug maker said on Friday, as coronavirus infections in\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/\" \/>\n<meta property=\"og:site_name\" content=\"The Purbottar\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/purbottarnewsportal\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-25T09:30:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-07-25T09:30:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i1.wp.com\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png?fit=870%2C470&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"870\" \/>\n\t<meta property=\"og:image:height\" content=\"470\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/\"},\"author\":{\"name\":\"editor\",\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/person\/6dc5246d014876c911f9358bb70c5abe\"},\"headline\":\"Cipla Gets Regulatory Nod To Sell COVID-19 Drug\",\"datePublished\":\"2020-07-25T09:30:57+00:00\",\"dateModified\":\"2020-07-25T09:30:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/\"},\"wordCount\":198,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/thepurbottar.in\/#organization\"},\"image\":{\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png\",\"keywords\":[\"CIPLA\"],\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/\",\"url\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/\",\"name\":\"Cipla Gets Regulatory Nod To Sell COVID-19 Drug - The Purbottar\",\"isPartOf\":{\"@id\":\"https:\/\/thepurbottar.in\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png\",\"datePublished\":\"2020-07-25T09:30:57+00:00\",\"dateModified\":\"2020-07-25T09:30:59+00:00\",\"description\":\"Cipla has received regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drug maker said on Friday, as coronavirus infections in\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage\",\"url\":\"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png\",\"contentUrl\":\"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png\",\"width\":870,\"height\":470},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepurbottar.in\/#website\",\"url\":\"https:\/\/thepurbottar.in\/\",\"name\":\"The Purbottar\",\"description\":\"English News Paper\",\"publisher\":{\"@id\":\"https:\/\/thepurbottar.in\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepurbottar.in\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepurbottar.in\/#organization\",\"name\":\"The Purbottar\",\"url\":\"https:\/\/thepurbottar.in\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepurbottar.in\/wp-content\/uploads\/2023\/08\/purbottar-english-logo-544px.png?fit=544%2C180&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepurbottar.in\/wp-content\/uploads\/2023\/08\/purbottar-english-logo-544px.png?fit=544%2C180&ssl=1\",\"width\":544,\"height\":180,\"caption\":\"The Purbottar\"},\"image\":{\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/purbottarnewsportal\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/person\/6dc5246d014876c911f9358bb70c5abe\",\"name\":\"editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8e6c701f02065fa555d91f62548bd0f8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8e6c701f02065fa555d91f62548bd0f8?s=96&d=mm&r=g\",\"caption\":\"editor\"}}]}<\/script>\n","yoast_head_json":{"title":"Cipla Gets Regulatory Nod To Sell COVID-19 Drug - The Purbottar","description":"Cipla has received regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drug maker said on Friday, as coronavirus infections in","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/","og_locale":"en_US","og_type":"article","og_title":"Cipla Gets Regulatory Nod To Sell COVID-19 Drug - The Purbottar","og_description":"Cipla has received regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drug maker said on Friday, as coronavirus infections in","og_url":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/","og_site_name":"The Purbottar","article_publisher":"https:\/\/www.facebook.com\/purbottarnewsportal\/","article_published_time":"2020-07-25T09:30:57+00:00","article_modified_time":"2020-07-25T09:30:59+00:00","og_image":[{"width":870,"height":470,"url":"https:\/\/i1.wp.com\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png?fit=870%2C470&ssl=1","type":"image\/png"}],"author":"editor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#article","isPartOf":{"@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/"},"author":{"name":"editor","@id":"https:\/\/thepurbottar.in\/#\/schema\/person\/6dc5246d014876c911f9358bb70c5abe"},"headline":"Cipla Gets Regulatory Nod To Sell COVID-19 Drug","datePublished":"2020-07-25T09:30:57+00:00","dateModified":"2020-07-25T09:30:59+00:00","mainEntityOfPage":{"@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/"},"wordCount":198,"commentCount":0,"publisher":{"@id":"https:\/\/thepurbottar.in\/#organization"},"image":{"@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png","keywords":["CIPLA"],"articleSection":["Business"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/","url":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/","name":"Cipla Gets Regulatory Nod To Sell COVID-19 Drug - The Purbottar","isPartOf":{"@id":"https:\/\/thepurbottar.in\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage"},"image":{"@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png","datePublished":"2020-07-25T09:30:57+00:00","dateModified":"2020-07-25T09:30:59+00:00","description":"Cipla has received regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drug maker said on Friday, as coronavirus infections in","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage","url":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png","contentUrl":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png","width":870,"height":470},{"@type":"WebSite","@id":"https:\/\/thepurbottar.in\/#website","url":"https:\/\/thepurbottar.in\/","name":"The Purbottar","description":"English News Paper","publisher":{"@id":"https:\/\/thepurbottar.in\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepurbottar.in\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepurbottar.in\/#organization","name":"The Purbottar","url":"https:\/\/thepurbottar.in\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepurbottar.in\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepurbottar.in\/wp-content\/uploads\/2023\/08\/purbottar-english-logo-544px.png?fit=544%2C180&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepurbottar.in\/wp-content\/uploads\/2023\/08\/purbottar-english-logo-544px.png?fit=544%2C180&ssl=1","width":544,"height":180,"caption":"The Purbottar"},"image":{"@id":"https:\/\/thepurbottar.in\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/purbottarnewsportal\/"]},{"@type":"Person","@id":"https:\/\/thepurbottar.in\/#\/schema\/person\/6dc5246d014876c911f9358bb70c5abe","name":"editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepurbottar.in\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8e6c701f02065fa555d91f62548bd0f8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8e6c701f02065fa555d91f62548bd0f8?s=96&d=mm&r=g","caption":"editor"}}]}},"jetpack_featured_media_url":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png","_links":{"self":[{"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/posts\/4586"}],"collection":[{"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/comments?post=4586"}],"version-history":[{"count":1,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/posts\/4586\/revisions"}],"predecessor-version":[{"id":4589,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/posts\/4586\/revisions\/4589"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/media\/4588"}],"wp:attachment":[{"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/media?parent=4586"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/categories?post=4586"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/tags?post=4586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/index.php:1) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/index.php:1) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/index.php:1) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/index.php:1) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/index.php:1) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/index.php:1) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/index.php:1) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home1/thepumlw/public_html/index.php:1) in /home1/thepumlw/public_html/wp-includes/rest-api/class-wp-rest-server.php on line 1831
{"id":4586,"date":"2020-07-25T09:30:57","date_gmt":"2020-07-25T09:30:57","guid":{"rendered":"http:\/\/thepurbottar.in\/?p=4586"},"modified":"2020-07-25T09:30:59","modified_gmt":"2020-07-25T09:30:59","slug":"cipla-gets-regulatory-nod-to-sell-covid-19-drug","status":"publish","type":"post","link":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/","title":{"rendered":"Cipla Gets Regulatory Nod To Sell COVID-19 Drug"},"content":{"rendered":"\n

Cipla has received regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drug maker said on Friday, as coronavirus infections in the world’s third worst-hit nation show no sign of abating. The Drug Controller General of India granted Cipla accelerated approval to make and sell favipiravir in an effort to meet the “urgent and unmet” need for COVID-19 treatment options in the country, the company said.<\/p>\n\n\n\n

India reported over 49,000 fresh cases of the novel coronavirus with 740 new deaths on Friday, marking the biggest daily surge in cases, as officials in some states complained of shortages of vital drugs for those hospitalized.<\/p>\n\n\n\n

Cipla said it would launch favipiravir as “Ciplenza” in the first week of August, priced at Rs 68 (91 cents) per 200 mg tablet.<\/p>\n\n\n\n

Separately on Friday, much smaller Indian drug maker Jenburkt Pharmaceuticals said it would launch its own version of favipiravir, priced at Rs 39 per tablet.<\/p>\n\n\n\n

Glenmark, meanwhile, sells a tablet of favipiravir for Rs 75, with a patient typically requiring 122 tablets over 14 days for a treatment course, the company said. On Thursday, Glenmark said its version of the drug had showed promise in a late-stage clinical trial.<\/p>\n\n\n\n

($1 = Rs 74.7997)<\/p>\n","protected":false},"excerpt":{"rendered":"

Cipla has received regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drug maker said on Friday, as coronavirus infections in the world’s […]<\/p>\n","protected":false},"author":2,"featured_media":4588,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[243],"yoast_head":"\nCipla Gets Regulatory Nod To Sell COVID-19 Drug - The Purbottar<\/title>\n<meta name=\"description\" content=\"Cipla has received regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drug maker said on Friday, as coronavirus infections in\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cipla Gets Regulatory Nod To Sell COVID-19 Drug - The Purbottar\" \/>\n<meta property=\"og:description\" content=\"Cipla has received regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drug maker said on Friday, as coronavirus infections in\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/\" \/>\n<meta property=\"og:site_name\" content=\"The Purbottar\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/purbottarnewsportal\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-25T09:30:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-07-25T09:30:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i1.wp.com\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png?fit=870%2C470&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"870\" \/>\n\t<meta property=\"og:image:height\" content=\"470\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/\"},\"author\":{\"name\":\"editor\",\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/person\/6dc5246d014876c911f9358bb70c5abe\"},\"headline\":\"Cipla Gets Regulatory Nod To Sell COVID-19 Drug\",\"datePublished\":\"2020-07-25T09:30:57+00:00\",\"dateModified\":\"2020-07-25T09:30:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/\"},\"wordCount\":198,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/thepurbottar.in\/#organization\"},\"image\":{\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png\",\"keywords\":[\"CIPLA\"],\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/\",\"url\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/\",\"name\":\"Cipla Gets Regulatory Nod To Sell COVID-19 Drug - The Purbottar\",\"isPartOf\":{\"@id\":\"https:\/\/thepurbottar.in\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png\",\"datePublished\":\"2020-07-25T09:30:57+00:00\",\"dateModified\":\"2020-07-25T09:30:59+00:00\",\"description\":\"Cipla has received regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drug maker said on Friday, as coronavirus infections in\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage\",\"url\":\"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png\",\"contentUrl\":\"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png\",\"width\":870,\"height\":470},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepurbottar.in\/#website\",\"url\":\"https:\/\/thepurbottar.in\/\",\"name\":\"The Purbottar\",\"description\":\"English News Paper\",\"publisher\":{\"@id\":\"https:\/\/thepurbottar.in\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepurbottar.in\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepurbottar.in\/#organization\",\"name\":\"The Purbottar\",\"url\":\"https:\/\/thepurbottar.in\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepurbottar.in\/wp-content\/uploads\/2023\/08\/purbottar-english-logo-544px.png?fit=544%2C180&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepurbottar.in\/wp-content\/uploads\/2023\/08\/purbottar-english-logo-544px.png?fit=544%2C180&ssl=1\",\"width\":544,\"height\":180,\"caption\":\"The Purbottar\"},\"image\":{\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/purbottarnewsportal\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/person\/6dc5246d014876c911f9358bb70c5abe\",\"name\":\"editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepurbottar.in\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8e6c701f02065fa555d91f62548bd0f8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8e6c701f02065fa555d91f62548bd0f8?s=96&d=mm&r=g\",\"caption\":\"editor\"}}]}<\/script>\n","yoast_head_json":{"title":"Cipla Gets Regulatory Nod To Sell COVID-19 Drug - The Purbottar","description":"Cipla has received regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drug maker said on Friday, as coronavirus infections in","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/","og_locale":"en_US","og_type":"article","og_title":"Cipla Gets Regulatory Nod To Sell COVID-19 Drug - The Purbottar","og_description":"Cipla has received regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drug maker said on Friday, as coronavirus infections in","og_url":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/","og_site_name":"The Purbottar","article_publisher":"https:\/\/www.facebook.com\/purbottarnewsportal\/","article_published_time":"2020-07-25T09:30:57+00:00","article_modified_time":"2020-07-25T09:30:59+00:00","og_image":[{"width":870,"height":470,"url":"https:\/\/i1.wp.com\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png?fit=870%2C470&ssl=1","type":"image\/png"}],"author":"editor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#article","isPartOf":{"@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/"},"author":{"name":"editor","@id":"https:\/\/thepurbottar.in\/#\/schema\/person\/6dc5246d014876c911f9358bb70c5abe"},"headline":"Cipla Gets Regulatory Nod To Sell COVID-19 Drug","datePublished":"2020-07-25T09:30:57+00:00","dateModified":"2020-07-25T09:30:59+00:00","mainEntityOfPage":{"@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/"},"wordCount":198,"commentCount":0,"publisher":{"@id":"https:\/\/thepurbottar.in\/#organization"},"image":{"@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png","keywords":["CIPLA"],"articleSection":["Business"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/","url":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/","name":"Cipla Gets Regulatory Nod To Sell COVID-19 Drug - The Purbottar","isPartOf":{"@id":"https:\/\/thepurbottar.in\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage"},"image":{"@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png","datePublished":"2020-07-25T09:30:57+00:00","dateModified":"2020-07-25T09:30:59+00:00","description":"Cipla has received regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drug maker said on Friday, as coronavirus infections in","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepurbottar.in\/cipla-gets-regulatory-nod-to-sell-covid-19-drug\/#primaryimage","url":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png","contentUrl":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png","width":870,"height":470},{"@type":"WebSite","@id":"https:\/\/thepurbottar.in\/#website","url":"https:\/\/thepurbottar.in\/","name":"The Purbottar","description":"English News Paper","publisher":{"@id":"https:\/\/thepurbottar.in\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepurbottar.in\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepurbottar.in\/#organization","name":"The Purbottar","url":"https:\/\/thepurbottar.in\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepurbottar.in\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepurbottar.in\/wp-content\/uploads\/2023\/08\/purbottar-english-logo-544px.png?fit=544%2C180&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepurbottar.in\/wp-content\/uploads\/2023\/08\/purbottar-english-logo-544px.png?fit=544%2C180&ssl=1","width":544,"height":180,"caption":"The Purbottar"},"image":{"@id":"https:\/\/thepurbottar.in\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/purbottarnewsportal\/"]},{"@type":"Person","@id":"https:\/\/thepurbottar.in\/#\/schema\/person\/6dc5246d014876c911f9358bb70c5abe","name":"editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepurbottar.in\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8e6c701f02065fa555d91f62548bd0f8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8e6c701f02065fa555d91f62548bd0f8?s=96&d=mm&r=g","caption":"editor"}}]}},"jetpack_featured_media_url":"https:\/\/thepurbottar.in\/wp-content\/uploads\/2020\/07\/1586441532_CKaZRV_cipla_1.png","_links":{"self":[{"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/posts\/4586"}],"collection":[{"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/comments?post=4586"}],"version-history":[{"count":1,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/posts\/4586\/revisions"}],"predecessor-version":[{"id":4589,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/posts\/4586\/revisions\/4589"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/media\/4588"}],"wp:attachment":[{"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/media?parent=4586"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/categories?post=4586"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepurbottar.in\/wp-json\/wp\/v2\/tags?post=4586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}